Georgia Code
Part 1 - Schedules, Offenses, and Penalties
§ 16-13-29. Schedule v

The controlled substances listed in this Code section are included in Schedule V:
(1.25) Cenobamate, including its salts;
(1.5) Reserved;
History. Code 1933, § 79A-810, enacted by Ga. L. 1974, p. 221, § 1; Ga. L. 1978, p. 1668, § 9; Ga. L. 1979, p. 859, § 9; Ga. L. 1980, p. 1746, § 8; Ga. L. 1981, p. 557, § 5; Ga. L. 1984, p. 1019, § 2; Ga. L. 1986, p. 1555, § 5; Ga. L. 1989, p. 233, § 5; Ga. L. 1993, p. 590, § 3; Ga. L. 2003, p. 349, § 5; Ga. L. 2007, p. 605, § 2/HB 286; Ga. L. 2010, p. 860, § 4/SB 353; Ga. L. 2011, p. 656, § 6/SB 93; Ga. L. 2012, p. 40, § 4/SB 370; Ga. L. 2015, p. 5, § 16/HB 90; Ga. L. 2017, p. 14, § 8/HB 231; Ga. L. 2019, p. 820, § 3/HB 483; Ga. L. 2020, p. 493, § 16/SB 429; Ga. L. 2021, p. 184, § 27/SB 195; Ga. L. 2021, p. 386, § 7/HB 367.
The 2017 amendment, effective April 17, 2017, deleted “or” at the end of paragraph (5), substituted a semicolon for a period at the end of paragraph (6), and added paragraph (7).
The 2019 amendment, effective May 7, 2019, added paragraph (1.5).
The 2020 amendment, effective July 29, 2020, part of an Act to revise, modernize, and correct the Code, substituted “rule making” for “rulemaking” in the first proviso of paragraph (5).
The 2021 amendments.
The first 2021 amendment, effective July 1, 2021, repealed paragraph (1.5), which formerly read: “Epidiolex: A drug product in finished dosage formulation in its original container that has been approved by and labeled in compliance with the U.S. Food and Drug Administration (FDA) that contains cannabidiol (CBD) derived from cannabis and contains no more than 0.1 percent (w/w) residual tetrahydrocannabinols”. The second 2021 amendment, effective May 4, 2021, added paragraph (1.25); substituted “Reserved” for “Epidiolex: A drug product in finished dosage formulation in its original container that has been approved by and labeled in compliance with the U.S. Food and Drug Administration (FDA) that contains cannabidiol (CBD) derived from cannabis and contains no more than 0.1 percent (w/w) residual tetrahydrocannabinols” in paragraph (1.5); substituted a semicolon for a period at the end of paragraph (7); and added paragraph (8).
Code Commission notes.
Pursuant to Code Section 28-9-5, in 2003, a semicolon was substituted for a period at the end of paragraph (2).
Pursuant to Code Section 28-9-5, in 2017, “or” was added at the end of paragraph (6).
Pursuant to Code Section 28-9-5, in 2021, “or” was deleted from the end of paragraph (6) and “or” was added at the end of paragraph (7).
Editor’s notes.
Ga. L. 2012, p. 40, § 1/SB 370, not codified by the General Assembly, which provides for the annual update of the identity of controlled substances and dangerous drugs, is dedicated to the memory of Chase Corbitt Burnett and shall be known and may be cited as “Chase’s Law.”
Ga. L. 2021, p. 184, § 28/SB 195, not codified by the General Assembly, provides that: “Nothing in this Act shall be deemed to change, amend, or alter any criteria for applications for a Class 1 or Class 2 production license submitted to the Georgia Access to Medical Cannabis Commission on or prior to January 27, 2021.”
Administrative rules and regulations.
Registration requirements under Georgia Controlled Substances Act, Official Compilation of the Rules and Regulations of the State of Georgia, Rules of Georgia State Board of Pharmacy, Chapter 480-20. Requirements of a prescription drug order, Official Compilation of the Rules and Regulations of the State of Georgia, Rules of Georgia State Board of Pharmacy, Chapter 480-22.

Structure Georgia Code